Several CAF-derived chemokines such as CCL2, CCL26, IL6, CXCL1, and CXCL8 mediate tumor progression, angiogenesis [4], and drug resistance [5–7], suggesting that tumor–CAF crosstalk is a bidirectional, dynamic, and adaptive process. This evidence concerns the gene CCL26 and neoplasm.